An irradiation-altered bone marrow microenvironment impacts anabolic actions of PTH

Endocrinology

Volumn 152, Issue 12, 2011, Pages 4525-4536

  Koh, A J ^a   Novince, C M ^a   Li, X ^a   Wang, T ^a   Taichman, R S ^a   McCauley, Laurie K ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; BETA1 INTEGRIN; CD11B ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; FIBRINOGEN RECEPTOR; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 6; MESSENGER RNA; NESTIN; PARATHYROID HORMONE[1-34]; STEM CELL FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MARROW; BONE MINERALIZATION; BONE TURNOVER; CELL COUNT; CELL CYCLE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMUR; GENE EXPRESSION; HORMONE ACTION; IN VITRO STUDY; IN VIVO STUDY; MEGAKARYOCYTE; MICROENVIRONMENT; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; RADIATION INJURY; SPLEEN WEIGHT; TIBIA; TRABECULAR BONE;

ANIMALS; BONE MARROW; CELL COUNT; CELLULAR MICROENVIRONMENT; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; OSTEOCLASTS; PARATHYROID HORMONE; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; WHOLE-BODY IRRADIATION;

EID: 82355188240     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1515     Document Type: Article

References (46)

1. Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, García-Hernández PA, Recknor CP, Einhorn TA, Dalsky GP, Mitlak BH, Fierlinger A, Lakshmanan MC 2010 Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausalwomenwith distal radial fractures. J Bone Miner Res 25:404-414
2. Bashutski JD, Eber RM, Kinney JS, Benavides E, Maitra S, Braun TM, Giannobile WV, McCauley LK 2010 Teriparatide and osseous regeneration in the oral cavity. New Engl J Med 363:2396-2405
3. Wei G, Pettway GJ, McCauley LK, Ma PX 2004 The release profiles and bioactivity of parathyroid hormone from poly(lactic co-glycoloic acid) microspheres. Biomaterials 25:345-352 (Pubitemid 37329723)
4. Adams GB, Martin RP, Alley IR, Chabner KT, Cohen KS, CalviLM, Kronenberg HM, Scadden DT 2007 Therapeutic targeting of a stem cell niche. Nat Biotechnol 25:238-243 (Pubitemid 46227124)
5. Poole KE, Reeve J 2005 Parathyroid hormone- a bone anabolic and catabolic agent. Curr Opin Pharmacol 5:612-617 (Pubitemid 41614461)
6. Nissenson RA, Jüppner H 2008 Parathyroid hormone. In: Favus M, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. 7th ed. Washington, DC: American Society for Bone and Mineral Research; 123-127
7. Wu X, Pang L, Lei W, Lu W, Li J, Li Z, Frassica FJ, Chen X, Wan M, Cao X 2010 Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling. Cell Stem Cell 7:571-580
8. Taichman RS 2005 Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem cell niche. Blood 105: 2631-2639 (Pubitemid 40446251)
9. Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, Saxton JM, Kronenberg HM, Baron R, Schipani E 2001 Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest 107:277-286 (Pubitemid 32157960)
10. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT 2003 Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841-846 (Pubitemid 37351468)
11. Pirih FQ, Michalski MN, Cho SW, Koh AJ, Berry JE, Ghaname E, Kamarajan P, Bonnelye E, RossCW,Kapila YL, Jurdic P, McCauleyLK 2010 Parathyroid hormone mediates hematopoietic cell expansion through interleukin-6. PLoS One 5:e13657
12. Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ 2003 The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. New Engl J Med 25: 1207-1215 (Pubitemid 37152030)
13. Koh AJ, Demiralp B, Neiva KG, Hooten J, Nohutcu RM, Shim H, Datta NS, Taichman RS, McCauley LK 2005 Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone. Endocrinology 146:4584-4596 (Pubitemid 41446596)
14. Samadfam R, Xia Q, Goltzman D 2007 Co-treatment of PTH with osteoprotegerin or alendronate increases its anabolic effect on the skeleton of oophorectomized Mice. J Bone Miner Res 22:53-66
15. Karsdal MA, Martin TJ, Bollerslev J, Christiansen C, Henriksen K 2007 Are non-resorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res 22:484-497
16. Yamashita J, Datta NS, Chun YH, Yang DY, Carey AA, Kreider JM, Goldstein SA, McCauley LK 2008 Role of Bcl-2 in osteoclastogenesis, cell survival, and PTH anabolic actions in bone. J Bone Miner Res 23:621-632 (Pubitemid 351575016)
17. Demiralp B, Chen HL, Koh AJ, Keller ET, McCauley LK 2002 Anabolic effects of parathyroid hormone during endochondral bone growth are dependent on c-fos. Endocrinology 143:4038-4047 (Pubitemid 35244383)
18. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP 2003 Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264
19. Benjamini Y, HochbergY2010 Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 57:289-300
20. Rosen CJ, Ackert-Bicknell C, Rodriguez JP, Pino AM 2009 Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Crit Rev Eukar Gene 19:109-124
21. Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ 2009 Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 460:259-263
22. Dominici M, Rasini V, Bussolari R, Chen X, Hofmann TJ, Spano C, Bernabei D,Veronesi E, Bertoni F, Paolucci P, Conte P, Horwitz EM 2009 Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation. Blood 114:2333-2343
23. Chang MK, Raggatt LJ, Alexander KA, Kuliwaba JS, Fazzalari NL, Schroder K, Maylin ER, Ripoll VM, Hume DA, Pettit AR 2008 Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol 181:1232-1244
24. Méndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN, Frenette PS 2010 Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466:829-834
25. Hurley MM, Yao M, Lane NE 2005 Changes in serum fibroblast growth factor 2 in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34). Osteoporosis Int 16:2080-2084 (Pubitemid 41790930)
26. Jung Y, Wang J, Schneider A, Sun YX, Koh-Paige AJ, Osman NI, McCauley LK, Taichman RS 2006 Regulation of SDF-1 (CXCL12) production by osteoblasts in the hematopoietic microenvironment and a possible mechanisms for stem cell homing. Bone 38:497-508
27. Fliedner TM, Graessle D, Paulsen C, Reimers K 2002 Structure and function of bone marrow hemopoiesis: mechanisms of response to ionizing radiation exposure. Cancer Biother Radio 17:405-427
28. Zhong JF, Zhan Y, Anderson WF, Zhao Y 2002 Murine hematopoietic stem cell distribution and proliferation in ablated and nonablated bone marrow transplantation. Blood 100:3521-3526 (Pubitemid 35303919)
29. Tanum G 1984 The megakaryocyte DNA content and platelet formation after the sublethal whole body irradiation of rats. Blood 63:917-920 (Pubitemid 14141315)
30. Witte DP, Stambrook PJ, Feliciano E, Jones CL, Lieberman MA 1988 Growth factor production by a human megakaryocytic tumor cell line. J Cell Physiol 137:86-94
31. Wang JC, Chang TH, Goldberg A, Novetsky AD, Lichter S, Lipton J 2006 Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia. Exp Hematol 34:1617-1623 (Pubitemid 44838997)
32. Kacena MA, Gundberg CM, Horowitz MC 2006 A reciprocal regulatory interaction between megakaryocytes, bone cells, and hematopoietic stem cells. Bone 39:978-984 (Pubitemid 44528390)
33. Zhang Q, Cuartas E, Mehta N, Gilligan J, Ke HZ, Saltzman WM, Kotas M, Ma M, Rajan S, Chalouni C, Carlson J, Vignery A 2008 Replacement of bone marrow by bone in rat femurs: the bone bioreactor. Tissue Eng Part A 14:237-246
34. Bab I, Gazit D, Muhlrad A, Shteyer A 1988 Regenerating bone marrow produces a potent growth-promoting activity to osteogenic cells. Endocrinology 123:345-352
35. Devlin MJ, Cloutier AM, Thomas NA, Panus DA, Lotinun S, Pinz I, Baron R, Rosen CJ, Bouxsein ML 2010 Caloric restriction leads to high marrow adiposity and low bone mass in growing mice. J Bone Miner Res 25:2078-2088
36. Han J, Koh YJ,MoonHR, Ryoo HG, Cho CH, Kim I, Koh GY 2010 Adipose tissue is an extramedullary reservoir for functional hematopoietic stem and progenitor cells. Blood 115:957-964
37. Jung Y, Song J, Shiozawa Y, Wang J, Wang Z, Williams B, Havens A, Schneider A, Ge C, Franceschi RT, McCauley LK, Krebsbach PH, Taichman RS 2008 Hematopoietic stem cells regulate development of their niche. Stem Cells 26:2042-2051
38. Hurley MM, Okada Y, Xiao L, Tanaka Y, Ito M, Okimoto N, Nakamura T, Rosen CJ, Doetschman T, Coffin JD 2006 Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice. Biochem Biophys Res Commun 341:989-994 (Pubitemid 43221763)
39. Xiao L, Sobue T, Esliger A, Kronenberg MS, Coffin JD, Doetschman T, Hurley MM 2010 Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells. Bone 47:360-370
40. Kalajzic I, Braut A, Guo D, Jiang X, Kronenberg MS, Mina M, Harris MA, Harris SE, Rowe DW 2004 Dentin matrix protein1 expression during osteoblast differentiation, generation of an osteocyte GFP-transgene. Bone 35:74-82 (Pubitemid 38789150)
41. Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF, Kudo A 1999 Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor β. J Bone Miner Res 14: 1239-1249 (Pubitemid 29314070)
42. Bonnet N, Standley KN, Bianchi EN, Stadelmann V, Foti M, Conway SJ, Ferrari SL 2009 The matricellular protein periostin is required for Sost inhibition and the anabolic response to mechanical loading and physical activity. J Biol Chem 284:35939-35950
43. Rios H, Koushik SV, Wang H, Wang J, Zhou HM, Lindsley A, Rogers R, Chen Z, Maeda M, Kruzynska-Frejtag A, Feng JQ, Conway SJ 2005 Periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol 25:11131-11144 (Pubitemid 41747153)
44. Nakazawa T, Nakajima A, Seki N, Okawa A, Kato M, Moriya H, Amizuka N, Einhorn TA, Yamazaki M 2004 Gene expression of periostin in the early stage of fracture healing detected by cDNA microarray analysis. J Orthopaed Res 22:520-525 (Pubitemid 38489728)
45. Zhu S, Barbe MF, Liu C, Hadjiargyrou M, Popoff SN, Rani S, Safadi FF, Litvin J 2009 Periostin-like-factor in osteogenesis. J Cell Physiol 218:584-592
46. Oku E, Kanaji T, Takata Y, Oshima K, Seki R, Morishige S, Imamura R, Ohtsubo K, Hashiguchi M, Osaki K, Yakushiji K, Yoshimoto K, Ogata H, Hamada H, Izuhara K, Sata M, Okamura T 2008 Periostin and bone marrow fibrosis. Int J Hematol 88:57-63